In ovarian cancer tissues, MAGE-1 and MAGE-3 were highly expressed with expression rates of 53.7% (22/41) and 36.6% (15/41), while GAGE-1/2 and BAGE had relatively low expression rates of 26.8% (11/41) and 14.6% (6/41). Here, MAGEA3 is linked to ovarian cancer.